Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price rose 50% during mid-day trading on Wednesday . The company traded as high as C$0.11 and last traded at C$0.11. Approximately 1,942,446 shares changed hands during trading, an increase of 1,795% from the average daily volume of 102,479 shares. The stock had previously closed at C$0.07.
Voyageur Pharmaceuticals Stock Performance
The firm has a 50-day simple moving average of C$0.07 and a two-hundred day simple moving average of C$0.06. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The company has a market capitalization of C$13.95 million, a price-to-earnings ratio of -10.00 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- What Are Earnings Reports?
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Energy and Oil Stocks Explained
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- What is a Secondary Public Offering? What Investors Need to Know
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
